/Companies

Cernostics

Pittsburgh, US · Delaware corporation · 7 known investors

Find your way into Cernostics

Sign up to see every warm intro you have to Cernostics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Cernostics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

MH
Michael HoerresExecutive

Board

JP
James PetersBoard director
SG
Steve GrenfellBoard director
PS
Paul SchmittBoard director
ND
Noel DohenyBoard director

Investors · 7

Also in the syndicate · 4

Ben Franklin Technology Partners of Northeastern PAGeisinger Health SystemNovitas CapitalUPMC Enterprises

Reported raises · per SEC filings

Form D private placements

$11.7M disclosed across 4 rounds · 2015–2021

▶$6MraisedAug 2021 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael J. HoerresExecutive Officer, Director
  • Tom WilliDirector
  • Noel DohenyDirector
  • Gregg FergusDirector
Offering amount
$12.5M
Amount sold
$6M
Minimum investment
$118.9K
First sale
Jul 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.5MraisedMar 2018 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Courtland LongestDirector
  • Michael HoerresExecutive Officer, Director
  • Noel DohenyDirector
  • Paul SchmittDirector
  • LeRoy MetzDirector
Offering amount
$2.5M
Amount sold
$2.5M
First sale
Mar 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.3MraisedAug 2016 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Noel DohenyDirector
  • LeRoy MetzDirector
  • Michael HoerresExecutive Officer, Director
  • Paul SchmittDirector
Offering amount
$5M
Amount sold
$1.3M
First sale
Aug 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2MraisedJun 2015 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Noel DohenyDirector
  • Michael HoerresExecutive Officer, Director
  • James PetersDirector
  • Steve GrenfellDirector
  • Paul SchmittDirector
Offering amount
$3.7M
Amount sold
$2M
First sale
May 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Non-dilutive funding · 2 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase II2015$1.2M
National Institutes of Health (NIH)National Institutes of HealthPhase I2009$147.3K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

In the news

Frequently asked questions

Who are Cernostics's investors?
Cernostics's investors include Illumina Ventures, Ben Franklin Technology Partners of Northeastern Pennsylvania, Pittsburgh Life Sciences Greenhouse.
How much funding has Cernostics raised?
Cernostics has disclosed $11.7M raised across 4 rounds.
Where is Cernostics headquartered?
Cernostics is headquartered in Pittsburgh, US.